The mesolimbic dopaminergic signaling, such as that originating from the ventral tegmental area (VTA) neurons in the medial part of the nucleus accumbens (mNAc), plays a role in complex sensory and affective components of pain. To date, we have demonstrated that optogenetic sensory nerve stimulation rapidly alters the dopamine (DA) content within the mNAc. However, the physiological role and biochemical processes underlying such rapid and regional dynamics of DA remain unclear. In this study, using imaging mass spectrometry (IMS), we observed that sensitized pain stimulation by optogenetic sensory nerve activation increased DA and 3-Methoxytyramine (3-MT; a post-synaptic metabolite obtained following DA degradation) in the mNAc of the experimental mice. To delineate the mechanism associated with elevation of DA and 3-MT, the de novo synthesized DA in the VTA/substantia nigra terminal areas was evaluated using IMS by visualizing the metabolic conversion of stable isotope-labeled tyrosine ( 13 C 15 N-Tyr) to DA. Our approach revealed that at steady state, the de novo synthesized DA occupied > 10% of the non-labeled DA pool in the NAc within 1.5 h of isotope-labeled Tyr administration, despite no significant increase following pain stimulation. These results suggested that sensitized pain triggered an increase in the release and postsynaptic intake of DA in the mNAc, followed by its degradation, and likely delayed de novo DA synthesis. In conclusion, we demonstrated that short, peripheral nerve excitation with mechanical stimulation accelerates the mNAc-specific DA signaling and metabolism which might be associated with the development of mechanical allodynia.
Introduction
The dopaminergic pathway, present from the ventral tegmental area (VTA) to the nucleus accumbens (NAc), is important for mediating acute and chronic pain sensations (Ikemoto, 2007; Taylor et al., 2016) and pain-avoidance behavior (Danjo et al., 2014) . The medial part of the NAc (mNAc) integrates signals from the mesencephalic dopaminergic neurons and other brain areas that process affective information (Britt et al., 2012; Bromberg-Martin et al., 2010) . Recent studies have shown that one projection of the mNAc, the indirect pathway (Bromberg-Martin et al., 2010) , is associated with the affective evaluation of events that shape behavior via interaction of dopamine (DA) with the D2 receptors (Ren et al., 2016) . This pathway participates in the central representation of pain, and controls the activity of the ascending nociceptive pathways (Ren et al., 2016) .
Accumulating evidence show that input from the VTA neurons, via DA signaling in the mNAc, plays a key role in the indirect pathway. We recently reported that activation of dopaminergic neurons in the VTA increases the amount of extracellular DA within the NAc, which blunts pathological allodynia induced by nerve injury or bone cancer (Watanabe et al., 2018a) . Moreover, manipulating the excitability of mNAc by administering a DA agonist diminishes mechanical allodynia in spared nerve injury models of neuropathic pain (Sarkis et al., 2011) . In contrast, aversive stimuli inhibit the dopaminergic neurons of the VTA (Danjo et al., 2014; Moriya et al., 2018; Ungless et al., 2004) .
To disentangle the complex sensory and affective components of pain, optogenetic manipulation of sciatic nerve neurons has been used to induce noninvasive excitation of nociceptors in freely moving mice (Iyer et al., 2014) . Using this method, we observed that exclusive excitation of the sciatic nerves by blue light lowered the pain threshold T but did not induce pain sensation, and was accompanied by a mNAcspecific reduction of DA as measured by imaging mass spectrometry (IMS) (Watanabe et al., 2018b) . IMS measures the biochemical content (Morikawa et al., 2012) , for example, the total amount of DA from each pixel in tissue sections (Shariatgorji et al., 2014) ; therefore, our observation indicated rapid and large fluctuations in the total amount of DA, most likely, manifested by the stored synaptic vesicular pool of DA at mNAc-nerve terminals, which may be associated with the reduced pain threshold. However, it remains unclear whether sensitized pain stimulation by optogenetic nerve excitation alters the regional DA content. Moreover, the biochemical processes mediating the fluctuation of DA need to be elucidated.
In this study, we approached this question by visualizing the regional DA content, as well as the metabolic conversion of stable isotopelabeled Tyr ( 13 C 15 N-Tyr) to DA ( 13 C 15 N-DA), using IMS. 
Material and methods

Mice
Male C57BL/6J mice (8-12 weeks old; Tokyo Laboratory Animals Science Co., Ltd., Tokyo, Japan) were housed (up to six per cage) and maintained in a temperature-controlled room (24 ± 1°C). All mice were maintained under a 12-h light-dark cycle (light was switched on at 8 a.m.), and behavioral tests were performed during the light phase. Food and water were provided ad libitum. All animal experiments were performed in accordance with the Guiding Principles for the Care and Use of Laboratory Animals, Hoshi University, as adopted by the Committee on Animal Research of Hoshi University.
Time course analysis of dopamine de novo synthesis
After 12-15 h of food deprivation, the mice received oral administrattion of 13 C 9 15 N 1 -Tyrosine ( 13 C 15 N-Tyr; Taiyo Nippon Sanso, Tokyo, Japan; 30 mg/mL in H 2 O, 10 μL/g body weight). After 0.5, 1.0, and 1.5 h, the mice were sacrificed and their brains were harvested and immediately flash frozen in solid CO 2 and stored at −80°C.
Activation of sensory neurons by blue light irradiation
Based on the protocol described by Iyer et al., we used an adenoassociated virus serotype 6 (AAV6) encoding the human synapsin 1 promoter to achieve neuron-specific expression of the blue light--sensitive cation channel, channelrhodopsin-2 (ChR2), (ET/TC) fused to enhanced yellow fluorescent protein (EYFP). The AAV6-hSyn-ChR2 (ET/TC)-EYFP or control AAV6-hSyn-EYFP were serotyped with AAV6 coat proteins and packaged at the viral vector core at Nagoya University. The final viral concentration was between 1 × 10 11 and 3 × 10 12 copies/mL. Aliquots of the viral solution were stored at −80°C until use.
To selectively express ChR2-EYFP or EYFP in the sensory nerves, AAV6-hSyn-ChR2 (ET/TC)-EYFP or control virus was microinjected into the sciatic nerve of C57BL/6J mice. Briefly, the mice were anesthetized under isoflurane (3%, inhalation) and a 2-cm incision was made to expose the sciatic nerve. The microinjection was performed with an internal cannula (Eicom, Kyoto, Japan) at a rate of 1 μL/min for 8 min using a gas-tight syringe (10 μL; Eicom) and pump (Model ESP-32; Eicom). Two weeks after the intrasciatic injection, following 16 h of food deprivation, the mice were orally administered with 0.5 h) to the plantar surface of the ipsilateral hind paw, 1.5 h after 13 C 15 N-Tyr administration. Thirty minutes after the optical stimulation, the mice were sacrificed the whole brains harvested and flash frozen in solid CO 2 and stored at −80°C.
Measurement of the sensitivity for tactile stimulus
To quantify the change in pain sensitivity to tactile stimulus induced by the optical activation of sensory nerves, the paw withdrawal response was measured, in response to a tactile stimulus during blue light stimulation (473 nm, CW) of the plantar surface, using von Frey filaments with a bending force of 0.16 g (AesthesioV R, DanMic Global, LLC, CA, USA). Each of the hind paws were tested individually. Paw withdrawal in response to tactile stimulus was evaluated by scoring as follows: 0, no response; 1, a slow and slight withdrawal response; 2, a slow and prolonged fiexion withdrawal response (sustained lifting of the paw) to the stimulus; 3, a quick withdrawal response away from the stimulus without flinching or licking, and 4, an intense withdrawal response away from the stimulus with brisk flinching and/or licking. Paw movements associated with locomotion or weight shifting were not considered as a response.
Imaging mass spectrometry
Thin sections (thickness, 8 μm) were cut with a cryomicrotome (CM3050, Leica Microsystems) and thaw-mounted on indium-tin-oxidecoated glass slides (Bruker Daltonics, MA, USA) at −16°C. After sectioning, deuterium-labeled dopamine (D 4 -DA; 5 μM in 50% MeOH; IsoSciences PA, USA), used as an internal standard, was spray-coated on the sections using a robotic sprayer device (SunCollect system, SunChrom, Friedrichsdorf, Germany). To perform on-tissue derivatization of monoamines (Shariatgorji et al., 2014) , the sections were manually spray-coated with a solution of 2,4-diphenyl-pyranylium (DPP) tetrafluoroborate salts (Sigma-Aldrich, MO, USA; 1.3 mg/mL in methanol) using an artistic airbrush (Procon Boy FWA Platinum 0.2-mm caliber airbrush, Mr. Hobby, Tokyo, Japan). Thereafter, the sections were automatically spray-coated with 2,5-dihydroxybenzoic acid as a matrix (40 mg/mL, dissolved in 50% methanol) using a robotic sprayer.
Data were acquired with an orbitrap mass spectrometer (QExactive Focus, Thermo Fisher Scientific) coupled with an atmospheric pressure scanning microprobe matrix-assisted laser desorption/ionization ion source (AP-SMALDI10, TransMIT GmbH, Giessen, Germany) or a linear ion trap mass spectrometer with another MALDI source (LTQ XL, Thermo Fisher Scientific). The raster step size was set at 80 μm (Fig. 1) , 120 μm (Fig. 2) , or 100 μm (Figs. 3 and 4) . were monitored with a precursor ion isolation width of m/z 1.0. Thereafter, the spectral data were transformed to image data and analyzed using ImageQuest 1.0.1 (Thermo Fisher Scientific), SCiLS 2019a (Bruker Daltonics) and ImageJ 1.51 (National Institutes of Health, USA) software.
Results
Mapping in situ concentrations of DA within the VTA/SN circuits
DA mapping by IMS revealed that in situ DA concentrations were unevenly distributed within the VTA/SN neuronal circuits. Tyrosine hydroxylase (TH)-positive neural somas were localized to the VTA/ substantia nigra (SN) regions; however, we found that DA was highly concentrated in CP and NAc terminal regions, with concentrations 10-fold higher than that in the SN and VTA (Fig. 1) . This observation E. Sugiyama, et al. Neurochemistry International 129 (2019) 104494 indicated that local de novo synthesis of DA and/or rapid monoamine recycling at the CP and NAc synapses facilitated the accumulation of high levels of DA in the terminal areas.
In situ metabolic turnover analysis of DA synthesis
Following the observation of regional differences in DA concentration, we sought to assess the mechanism underlying the maintenance of high DA levels in the CP and NAc. To answer this, we evaluated the involvement of de novo synthesized DA in these terminal regions. Stable isotope-labeled Tyr ( 13 C 15 N-Tyr) was orally administered to mice, and its conversion to de novo synthesized, labeled DA ( 13 C 15 N-DA) was visualized in the brain sections comprising the CP and NAc at 0.5, 1.0, and 1.5 h after administration (Fig. 2a-c) . The results revealed an unexpectedly fast replacement of the total DA pool with the de novo synthesized, labeled DA, within 1.5 h of 13 C 15 N-Tyr administration. The newly synthesized DA increasingly accumulated in the terminal area ( Fig. 2c and d) , and eventually, occupied > 10% of the non-labeled DA in the three terminal regions such as: CP, mNAc, and lNAc (Fig. 2e) . In addition, an uneven rate of DA replacement between the brain regions was observed, with the mNAc exhibiting a lower replacement rate than that in the CP. These data indicate that a continuous and large supply of newly synthesized DA accumulates at the terminal regions to produce large storage pools of DA.
3.3. Sensitized pain stimulation during optogenetic sensory nerve activation increased regional levels of DA and 3-MT in mNAc
Since DA signaling in the NAc affects the pathological formation of allodynia (Watanabe et al., 2018a) , subsequently, we hypothesized that sensitized pain sensation might accompany spatiotemporal DA fluctuation within the VTA/SN circuits. To verify this hypothesis, mice expressing ChR2-EYFP or EYFP were fed with 13 C 15 N-Tyr (Fig. 3a) and subjected to von Frey filament test for tactile stimulus during optogenetic stimulation with blue light irradiation. The results show a clear elevation in allodynia score in mice expressing EYFP-ChR2 (Fig. 3b) . Thereafter, their regional DA contents were visually examined in coronal sections at two positions within the CP/NAc and VTA, respectively (Fig. 3c, Supplementary Fig. 1 ). Interestingly, EYFP-ChR2 group exhibiting elevated allodynia score showed significantly higher DA content in the mNAc, than EYFP-group ( Fig. 3d and e) . This spatiotemporal increase in DA accompanied no significant increase in the de novo synthesized 13 C 15 N-DA.
Moreover, amount of 3-MT, a post-synaptic metabolite of DA degradation, increased over a wide area, including the CP, lNAc, and mNAc ( Fig. 3d and e) . These results suggest that tactile stimulation during blue light irradiation increased the release of DA, followed by its post-synaptic degradation to 3-MT, after which, the mNAc presumably received preferential supply (i.e., de novo synthesis and/or reuptake) of DA. Additionally, we found that the VTA showed a higher de novo E. Sugiyama, et al. Neurochemistry International 129 (2019) 104494 synthesized DA replacement rate than did the other three regions ( Supplementary Fig. 1 ). These data indicate that the VTA has a higher activity of TH-driven DA synthesis and smaller pools of stored DA than that in the terminal regions.
3.4. Sciatic nerve excitation without tactile stimulation induced a reduction of DA in striatum but did not impair de novo DA synthesis
Optogenetic excitation of the sciatic nerve, without mechanical stimulation, induces aversion behavior in mice expressing ChR2-EYFP (Iyer et al., 2014) ; thus, we assessed the regional DA dynamics in mice under such condition. After the administration of stable isotope-labeled Tyr ( 13 C 15 N-Tyr), brains were harvested from mice who received and did not receive blue light stimulation for 30 min (Fig. 4a) . Interestingly, visualization by IMS demonstrated significant reduction of non-labeled DA in the CP and NAc terminal regions; however, no change was detected in the VTA (Fig. 4b and c, Supplementary Fig. 2 ). In contrast, the level of labeled DA remained unaltered in the CP and NAc, whereas slight reduction was observed in the VTA (Fig. 4c , Supplementary  Fig. 2 ). Taken together, only those mice which received blue light stimulation without tactile stimulation showed reduced amount of DA in wide areas of the CP and NAc terminal regions, as well as suppressed de novo DA synthesis within the VTA.
Discussion
In this study, we demonstrated the presence of a high homeostatic level of DA in the striatum sub-regions, with a continuous supply of de novo synthesized DA. The de novo synthesized DA occupied a significant proportion of the non-labeled DA pool in the sub-regions within 1.5 h of 13 C 15 N-Tyr administration. Although our results are consistent with that of previous studies demonstrating fast DA turnover (Karoum et al., 1984; Kilts and Anderson, 1987) , our technique provided spatially resolved information on the metabolic turnover of DA as high resolution images. The DA levels visualized by IMS represent the sum of the intra-and extra-cellular DA concentration at any given pixel. Because the concentration of intracellular DA is typically much higher than E. Sugiyama, et al. Neurochemistry International 129 (2019) 104494 extracellular DA (Ortiz et al., 2010) , the DA dynamics observed in this study predominantly reflect changes in the intracellular DA concentration, most likely present in storage vesicle, localized at the nerve terminals (Kai-Kai, 1984) . To overcome this technical challenge, we developed a micro-dialysis technique coupled with mass spectrometry (Watanabe et al., 2018b) to enable the comprehensive measurement of extra-cellular metabolites of DA degradation. Thus, the evaluation of vesicle-secreted DA and related metabolites, including stable isotopelabeled DA, by the microdialysis-mass spectrometry, is an important complementary approach for further study of DA metabolism. Our IMS-based approach revealed elevated levels of DA and 3-MT in the NAc terminals following short-term tactile stimulus, sensitized by optogenetic excitation of the sciatic nerve. Thus, it is reasonable to state that DA metabolism, i.e., release and post-synaptic uptake followed by decomposition of DA, was activated during pain sensation, although the reuptake activity was not examined (Fig. 5) . A recent report supports this suggestion; Mikhailova et al. showed that tail pinch treatment increased extra-cellular DA concentration in the NAc, whereas only touch stimulus did not alter the NAc DA concentration (Mikhailova et al., 2019) . Other studies reported that pain stimuli, in addition to analgesia, increased the extra-cellular DA concentration in the NAc (Kato et al., 2016; Navratilova et al., 2015) , suggesting that activated DA metabolism might be a feedback reaction to sensations of acute pain, and may play a role to attenuate the excess pain stimuli in the NAc.
On the contrary, in the striatum, optogenetic sensory nerve stimulation or tactile stimulus did not change the level of isotope-labeled DA (Fig. 4c) . In contrast, a slight but significant decrease in isotope-labeled DA was observed in the VTA by optogenetic sensory nerve stimulation ( Supplementary Fig. 2 ). These results suggest that DA production is more stable in the striatum than in the VTA. These observations may be congruent to reports which state that acute aversive stimuli induce a robust increase in extracellular DA level in the NAc but inhibits the firing of VTA DA neurons (Holly and Miczek, 2016; Ungless et al., 2004 ). An alternative interpretation of the unaffected de novo DA synthesis in mNAc is that such elevation of DA synthesis might be a slow process, and thus, the present results only show a marginal increase following optogenetic and tactile stimuli, which is statistically insignificant (Fig. 3e) . In future studies, this hypothesis can be validated by assessing the de novo DA synthesis at a later time point from that of isotope-labeled Tyr administration. Nonetheless, large and stable local de novo DA synthesis within the terminal structures of the striatal nerve terminal is suggested to be a major source of DA, as opposed to its transportation from the VTA (Fibiger et al., 1973) . In support of this suggestion, a previous study showed that restoration of DA synthesis in the striatal sub-regions, by region-specific TH expression alone, is sufficient, at least in part, to recover the affected behaviors in a DA deficient mouse model (Szczypka et al., 2001) .
In summary, we show that the DA neurons in the mNAc increases the biochemical pool of DA in response to the short-term pain sensation. However, the detailed molecular mechanism and its pathophysiological significance remains unclear. Here, we only examined acute pain stimulation. On the contrary, Ren et al. (2016) reported that the basal extracellular DA level is decreased in the spared nerve injury model of chronic neuropathic pain. In addition, a single, acute stress promotes long-lasting neuroplastic changes in the VTA dopaminergic neurons (Graziane et al., 2013; Saal et al., 2003) . Therefore, further study examining the biochemical DA metabolism between acute and chronic pain models should be conducted. We believe that our biochemistrybased data offer unique information on DA metabolism in various brain regions linked to the mesolimbic dopaminergic pathway, and on the possible mechanisms by which the changes in the level of this monoamine may shape the sensory and affective components of pain.
Conclusions
IMS-based visualization of monoamine neurotransmitters represents the sum of intra-and extra-cellular concentrations, most likely, the concentration of vesicular DA stored at the nerve terminals. Using this technique, we have revealed high homeostatic level of DA in the mNAc with continuous supply of de novo synthesized DA. Optogenetic and tactile stimulation of the sciatic nerve triggers an acute increase in DA level in the mNAc, whereas only optogenetic stimulation caused the opposite, i.e., a reduction in DA level. This study demonstrated that rapid and region-specific fluctuations in the concentration of monoamines occur in response to a sensitized, pain stimuli, and might be associated with the formation of allodynia.
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